Embion, Asahi Group Enter Strategic Collaboration

Plan to develop new products from brewing by-products generated by Asahi Group.

By: Contract Pharma

Contract Pharma Staff

Embion Technologies S.A., an industrial biotechnology and green chemistry innovator, and Asahi Group Holdings Ltd. (AGH) and its R&D subsidiary company, Asahi Quality and Innovations Ltd. (AQI) will cooperate to develop and deliver new products by combining each partners’ expertise and know-how.   As part of this partnership, Embion has already raised part of the Series A funding round which opened earlier in mid-November, with existing shareholders’ strong expected participation.   The ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters